Regulation of B-cell signal transduction by adaptor proteins

Nature Reviews Immunology

Volumn 2, Issue 5, 2002, Pages 354-363

  Kurosaki, Tomohiro ^a,b  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b RIKEN   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CELL SURFACE RECEPTOR; ENZYME; LYMPHOCYTE ANTIGEN RECEPTOR; B CELL LINKER PROTEIN; CARRIER PROTEIN; MEMBRANE PROTEIN; PAG PROTEIN, MOUSE; PHOSPHATIDYLINOSITOL; PHOSPHOPROTEIN; PROTEIN TYROSINE KINASE; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELLULAR DISTRIBUTION; CONFORMATIONAL TRANSITION; ENZYME ACTIVITY; IMMUNE RESPONSE; IMMUNE SYSTEM; NEGATIVE FEEDBACK; POSITIVE FEEDBACK; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; BIOLOGICAL MODEL; CELL MEMBRANE; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; B-LYMPHOCYTES; CARRIER PROTEINS; MEMBRANE MICRODOMAINS; MEMBRANE PROTEINS; MODELS, IMMUNOLOGICAL; PHOSPHATIDYLINOSITOLS; PHOSPHOPROTEINS; PROTEIN-TYROSINE KINASES; RECEPTORS, ANTIGEN, B-CELL; SIGNAL TRANSDUCTION;

EID: 0036584284     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri801     Document Type: Review

References (101)

1. Leo, A. & Schraven, B. Adapters in lymphocyte signalling. Curr. Opin. Immunol. 13, 307-316 (2001).
2. Campbell, K. S. Signal transduction from the B-cell antigen-receptor. Curr. Opin. Immunol. 11, 256-264 (1999).
3. Kelly, M. E. & Chan, A. C. Regulation of B-cell function by linker proteins. Curr. Opin. Immunol. 12, 267-275 (2000).
4. Annaiah, C. & Pillai, S. Antigen-dependent B-cell development. Curr. Opin. Immunol. 14, 241-249 (2002).
5. Fruman, D. A., Satterthwaite, A. B. & Witte, O. N. Xid-like phenotypes: a B-cell signalasome takes shape. Immunity 13, 1-3 (2000).
6. Kurosaki, T. Regulation of B-cell fates by BCR signaling components. Curr. Opin. Immunol. (in the press).
7. Pierce, S. K. Lipid rafts and B-cell activation. Nature Rev. Immunol. 2, 96-105 (2002).
8. DeFranco, A. L. The complexity of signaling pathways activated by the BCR. Curr. Opin. Immunol. 9, 296-308 (1997).
9. Kurosaki, T. Molecular mechanisms in B-cell antigen-receptor signaling. Curr. Opin. Immunol. 9, 309-318 (1997).
10. Reth, M. & Wienands, J. Initiation and processing of signals from the B-cell antigen receptor. Annu. Rev. Immunol. 15, 453-479 (1997).
11. Tamir, I. & Cambier, J. C. Antigen-receptor signaling: integration of protein tyrosine kinase functions. Oncogene 17, 1353-1364 (1998).
12. Simons, K. & Toomre, D. Lipid rafts and signal transduction. Nature Rev. Mol. Cell Biol. 1, 31-39 (2000).
13. Cherukuri, A., Dykstra, M. & Pierce, S. K. Floating the raft hypothesis: lipid rafts play a role in immune-cell activation. Immunity 14, 657-660 (2001).
14. Cheng, P. C., Dykstra, M. L., Mitchell, R. N. & Pierce, S. K. A role for lipid rafts in B-cell antigen receptor signaling and antigen targeting. J. Exp. Med. 190, 1549-1560 (1999). This study shows that BCR components, after BCR crosslinking, enter into rafts, which include LYN, but not CD45.
15. Guo, B., Kato, R. M., Garcia-Lloret, M., Wahl, M. I. & Rawlings, D. J. Engagement of the human pre-B-cell receptor generates a lipid raft-dependent calcium signaling complex. Immunity 13, 243-253 (2000).
16. Chung, J. B., Baumeister, M. A. & Monroe, J. G. Cutting edge: differential sequestration of plasma membrane-associated B-cell antigen receptor in mature and immature B cells into glycosphingolipid-enriched domains. J. Immunol. 166, 736-740 (2001).
17. Sproul, T. W., Malapati, S., Kim, J. & Pierce, S. K. Cutting edge: B-cell antigen receptor signaling occurs outside lipid rafts in immature B cells. J. Immunol. 165, 6020-6023 (2000).
18. Weintraub, B. C. et al. Entry of B-cell receptor into signaling domains is inhibited in tolerant B cells. J. Exp. Med. 191, 1443-1448 (2000).
19. Cherukuri, A., Cheng, P. C., Sohn, H. W. & Pierce, S. K. The CD19/CD21 complex functions to prolong B-cell antigen receptor signaling from lipid rafts. Immunity 14, 169-179 (2001). This study shows that co-ligation of BCR and CD19-CD 21 enhances the residency of both of these receptors in lipid rafts and retards the internalization and degradation of the BCR.
20. Dykstra, M. L., Longnecker, R. & Pierce, S. K. Epstein-Barr virus coopts lipid rafts to block the signaling and antigen-transport functions of the BCR. Immunity 14, 57-67 (2001).
21. Kurosaki, T. Genetic analysis of B-cell antigen-receptor signaling. Annu. Rev. Immunol. 17, 555-592 (1999).
22. Cooper, J. A. & Howell, B. The when and how of Src regulation. Cell 73, 1051-1054 (1993).
23. Hata, A., Sabe, H., Kurosaki, T., Takata, M. & Hanafusa, H. Functional analysis of Csk in signal transduction through the B-cell antigen receptor. Mol Cell Biol. 14, 7306-7313 (1994).
24. Yanagi, S. et al. CD45 modulates phosphorylation of bath autophosphorylation and negative regulatory tyrosines of Lyn in B cells. J. Biol. Chem. 271, 30467-30492 (1996).
25. Kawabuchi, M. et al. Transmembrane phosphoprotein Cbp regulates the activities of Src-family tyrosine kinases. Nature 404, 999-1003 (2000).
26. Brdicka, T. et al. Phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), a novel ubiquitously expressed transmembrane adaptor protein, binds the protein tyrosine kinase Csk and is involved in regulation of T-cell activation. J. Exp. Med. 191, 1591-1604 (2000). References 25 and 26 describe the purification and molecular cloning of a novel raft-associated adaptor protein that recruits the tyrosine kinase Csk to the plasma membrane.
27. Takeuchi, S., Takayama, Y., Ogawa, A., Tamura, K. & Okada, M. Transmembrane phosphoprotein Cbp positively regulates the activity of the carboxyl-terminal Src kinase, Csk. J. Biol. Chem. 275, 29183-29186 (2000)
28. Harder, K. W. et al. Gain- and loss-of-function Lyn-mutant mice define a critical inhibitory role for Lyn in the myeloid lineage. Immunity 15, 603-615 (2001)
29. Hakak, Y. & Martin, G. S. Ubiquitin-dependent degradation of active Src. Curr. Biol. 9, 1039-1042 (1999).
30. Harris, K. F. et al. Ubiquitin-mediated degradation of active Src tyrosine kinase. Proc. Natl Acad. Sci. USA 96, 13738-13743 (1999).
31. Fruman, D. A., Satterthwaite, A. B. & Witte, O. N. Xid-like phenotypes: a B-cell signalosome takes shape. Immunity 13, 1-3 (2000).
32. Rawlings, D. J. Bruton's tyrosine kinase controls a sustained calcium signal essential for B-lineage development and function. Clin. Immunol. 91, 243-253 (1999).
33. Takata, M. & Kurosaki, T. A role for Bruton's tyrosine kinase in B-cell antigen receptor-mediated activation of phospholipase C-γ2. J. Exp. Med. 184, 31-40 (1996).
34. Kang, S. W. et al. PKCβ modulates antigen receptor signaling via regulation of Btk membrane localization. EMBO J. 20, 5692-5702 (2001). This study describes the identification of Ser180, a Pkcβ target, in a short linker within the TH domain of Btk. Mutation of this phosphorylation site led to enhanced tyrosine phosphorylation and membrane association of Btk. This result led the authors to propose that Pkcβ, once activated by the Btk-Plcγ2 pathway, acts as a feedback-loop inhibitor of Btk activation.
35. Liu, W. et al. Direct inhibition of Bruton's tyrosine kinase by IBtk, a Btk-binding protein. Nature Immunol. 2, 939-946 (2001).
36. Yamadori, T. et al. Bruton's tyrosine kinase activity is negatively regulated by Sab, the Btk-SH3 domain-binding protein. Proc. Natl Acad. Sci. USA 96, 6341-6346 (1999).
37. Wang, D. et al. Phospholipase Cγ2 is essential in the functions of B-cell and several Fc receptors. Immunity 13, 25-35 (2000).
38. Hashimoto, A. et al. Cutting edge: essential role of phospholipase Cγ2 in B-cell development and function. J. Immunol. 165, 1738-1742 (2000).
39. Suzuki, H. et al. Xid-like immunodeficiency in mice with disruption of the p85α subunit of phosphoinositide 3-kinase. Science 283, 390-392 (1999).
40. Fruman, D. A. et al. Impaired B-cell development and proliferation in absence of phosphoinositide 3-kinase p85α. Science 283, 393-397 (1999).
41. Liu, Q. et al. The inositol polyphosphate 5-phosphatase SHIP is a crucial negative regulator of B-cell antigen-receptor signaling. J. Exp. Med. 188, 1333-1342 (1998).
42. -/- mice. J. Exp. Med. 191, 781-794 (2000).
43. Pike, L. J. & Miller, J. M. Cholesterol depletion delocalizes phosphatidylinositol bisphosphate and inhibits hormone-stimulated phosphatidylinositol turnover. J. Biol. Chem. 273, 22298-22304 (1998).
44. 2+ flux. Curr. Biol. 10, 393-396 (2000).
45. Richards, J. D., Gold, M. R., Hourihane, S. L., DeFranco, A. L. & Matsuuchi, L. Reconstitution of B-cell antigen receptor-induced signaling events in a nonlymphoid cell line by expressing the Syk protein-tyrosine kinase. J. Biol. Chem. 271, 6458-6466 (1996).
46. Wienands, J. et al. SLP-65: a new signaling component in B lymphocytes which requires expression of the antigen receptor for phosphorylation. J. Exp. Med. 188, 791-795 (1998).
47. Fu, C., Turck, C. W., Kurosaki, T. & Chan, A. C. BLNK: a central linker protein in B-cell activation. Immunity 9, 93-103 (1998).
48. Goitsuka, R. et al. BASH, a novel signaling molecule preferentially expressed in B cells of the bursa of Fabricius. J. Immunol. 161, 5804-5808 (1998).
49. Gangi-Peterson, L. et al. Bca: an activation-related B-cell gene. Mol. Immunol. 35, 55-63 (1998).
50. Ishiai, M., Sugawara, H., Kurosaki, M. & Kurosaki, T. Cutting edge: association of phospholipase C-γ2 Src homology 2 domains with BLNK is critical for B-cell antigen receptor signaling. J. Immunol. 163, 1746-1749 (1999).
51. Ishiai, M. et al. BLNK required for coupling Syk to PLCγ2 and Rac1-JNK in B cells. Immunity 10, 117-125 (1999).
52. Zhang, W., Sloan-Lancaster, J., Kitchen, J., Trible, R. P. & Samelson, L. E. LAT: the ZAP-70 tyrosine kinase substrate that links T-cell receptor to cellular activation. Cell 92, 83-92 (1998).
53. Zhang, W., Trible, R. P. & Samelson, L. E. LAT palmitoylation: its essential role in membrane microdomain targeting and tyrosine phosphorylation during T-cell activation. Immunity 9, 239-246 (1998).
54. Ishiai, M. et al. Involvement of LAT, Gads and Grb2 in compartmentation of SLP-76 to the plasma membrane. J. Exp. Med. 192, 847-856 (2000).
55. Boerth, N. J. et al. Recruitment of SLP-76 to the membrane and glycolipid-enriched membrane microdomains replaces the requirement for linker for activation of T cells in T-cell receptor signaling. J. Exp. Med. 192, 1047-1058 (2000).
56. Engels, N., Wollscheid, B. & Wienands, J. Association of SLP-65/BLNK with the B-cell antigen receptor through a non-ITAM tyrosine of Ig-α. Eur. J. Immunol. 31, 2126-2134 (2001).
57. Hashimoto, S. et al. Identification of the SH2-domain-binding protein of Bruton's tyrosine kinase as BLNK: functional significance of Btk-SH2 domain in B-cell antigen receptor-coupled calcium signaling. Blood 94, 2357-2364 (1999).
58. Su, Y. W. et al. Interaction of SLP adaptors with the SH2 domain of Tec family kinases. Eur. J. Immunol. 29, 3702-3711 (1999).
59. Baba, Y. et al. BLNK mediates Syk-dependent Btk activation. Proc. Natl Acad. Sci. USA 98, 2582-2586 (2001).
60. Yablonski, D., Kadlecek, T. & Weiss, A. Identification of a phospholipase C-γ (PLC-γ) SH3 domain-binding site in SLP-76 required for T-cell receptor-mediated activation of PLC-γ and NFAT. Mol. Cell. Biol. 21, 4208-4218 (2001).
61. Pappu, R. et al. Requirement for B-cell linker protein (BLNK) in B-cell development. Science 286, 1949-1954 (1999).
62. Jumaa, H. et al. Abnormal development and function of B lymphocytes in mice deficient for the signaling adaptor protein SLP-65. Immunity 11, 547-554 (1999).
63. Otero, D. C., Omori, S. A. & Rickert, R. C. CD19-dependent activation of Akt kinase in B lymphocytes. J. Biol. Chem. 276, 1474-1478 (2001).
64. Buhl, A. M. & Cambier, J. C. Phosphorylation of CD19 Y484 and Y515, and linked activation of phosphatidylinositol 3-kinase, are required for B-cell antigen receptor-mediated activation of Bruton's tyrosine kinase. J. Immunol. 162, 4438-4446 (1999).
65. 2+ mobilization is integrated by CD19 dephosphorylation. Immunity 7, 49-58 (1997).
66. Hayami, K. et al. Molecular cloning of a novel murine cell-surface glycoprotein homologous to killer-cell inhibitory receptors. J. Biol. Chem. 272, 7320-7327 (1997).
67. Kubagawa, H., Burrows, P. D. & Cooper, M. D. A novel pair of immunoglobulin-like receptors expressed by B cells and myeloid cells. Proc. Natl Acad. Sci. USA 94, 5261-5266 (1997).
68. Blery, M. et al. The paired Ig-like receptor PIR-B is an inhibitory receptor that recruits the protein-tyrosine phosphatase SHP-1. Proc. Natl Acad. Sci. USA 95, 2446-2451 (1998).
69. Maeda, A., Kurosaki, M., Ono, M., Takai, T. & Kurosaki, T. Requirement of SH2-containing protein tyrosine phosphatases SHP-1 and SHP-2 for paired immunoglobulin-like receptor B (PIR-B)-mediated inhibitory signal. J. Exp. Med. 187, 1355-1360 (1998).
70. Maeda, A. et al. Paired immunoglobulin-like receptor B (PIR-B) inhibits BCR-induced activation of Syk and Btk by SHP-1. Oncogene 18, 2291-2297 (1999).
71. Ho, L. H., Uehara, T., Chen, C. C., Kubagawa, H. & Cooper, M. D. Constitutive tyrosine phosphorylation of the inhibitory paired Ig-like receptor PIR-B. Proc. Natl Acad. Sci. USA 96, 15086-15090 (1999).
72. Tsui, F. W. & Tsui, H. W. Molecular basis of the motheaten phenotype. Immunol. Rev. 138, 185-206 (1994).
73. Cyster, J. G. & Goodnow, C. C. Protein tyrosine phosphatase 1C negatively regulates antigen receptor signaling in B lymphocytes and determines thresholds for negative selection. Immunity 2, 13-24 (1995).
74. Fearon, D. T. & Carroll, M. C. Regulation of B-lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex. Annu. Rev. Immunol. 18, 393-422 (2000).
75. Fujimoto, M. et al. CD19 regulates Src family protein tyrosine kinase activation in B lymphocytes through processive amplification. Immunity 13, 47-57 (2000).
76. Otero, D. C., Omori, S. A. & Rickert, R. C. CD19-dependent activation of Akt kinase in B lymphocytes. J. Biol. Chem. 276, 1474-1478 (2001).
77. Engel, P. et al. Abnormal B-lymphocyte development, activation and differentiation in mice that lack or overexpress the CD19 signal-transduction molecule. Immunity 3, 39-50 (1995).
78. Rickert, R. C., Rajewsky, K. & Roes, J. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 376, 352-355 (1995).
79. Okada, T., Maeda, A., Iwamatsu, A., Gotoh, K. & Kurosaki, T. BCAP: the tyrosine kinase substrate that connects B-cell receptor to phosphoinositide 3-kinase activation. Immunity 13, 817-827 (2000).
80. Ingham, R. J., Holgado-Madruga, M., Siu, C., Wong, A. J. & Gold, M. R. The Gab1 protein is a docking site for multiple proteins involved in signaling by the B-cell antigen receptor. J. Biol. Chem. 273, 30630-30637 (1998).
81. Gu, H. et al. Essential role for Gab2 in the allergic response. Nature 412, 186-190 (2001).
82. Pike, L. J. & Miller, J. M. Cholesterol depletion delocalizes phosphatidylinositol bisphosphate and inhibits hormone-stimulated phosphatidylinositol turnoven. J. Biol. Chem. 273, 22298-22304 (1998).
83. Manetz, T. S. et al. Vav1 regulates phospholipase Cγ activation and calcium responses in mast cells. Mol. Cell. Biol. 21, 3763-3774 (2001).
84. Inabe, K. et al. Vav3 modulates B-cell receptor responses by regulating phosphoinositide 3-kinase activation. J. Exp. Med. 195, 189-200 (2002). References 83 and 84 describe how loss of Vav-family proteins leads to insufficient PI3K activation in the context of FcεRI, BCR and TCR signalling.
85. Zheng, Y., Bagrodia, S. & Cerione, R. A. Activation of phosphoinositide 3-kinase activity by Cdc42Hs binding to p85. J. Biol. Chem. 269, 18727-18730 (1994).
86. Bokoch, G. M., Vlahos, C. J., Wang, Y., Knaus, U. G. & Traynor-Kaplan, A. E. Rac GTPase interacts specifically with phosphatidylinositol 3-kinase. Biochem. J. 315, 775-779 (1996).
87. Bustelo, X. R. Regulatory and signaling properties of the Vav family. Mol. Cell. Biol. 20, 1461-1477 (2000).
88. Bolland, S., Pearse, R. N., Kurosaki, T. & Ravetch, J. V. SHIP modulates immune receptor responses by regulating membrane association of Btk. Immunity 8, 509-516 (1998).
89. Ono, M. Bolland, S., Tempst, P. & Ravetch, J. V. Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor FcγRIIB. Nature 383, 263-266 (1996).
90. Ono, M. et al. Deletion of SHIP or SHP-1 reveals two distinct pathways for inhibitory signaling. Cell 90, 293-301 (1997).
91. 2+ oscillatory response. J. Immunol. 161, 5129-5132 (1998).
92. Petrie, R. J., Schnetkamp, P. P., Patel, K. D., Awasthi-Kalia, M. & Deans, J. P. Transient translocation of the B-cell receptor and Src homology 2 domain-containing inositol phosphatase to lipid rafts: evidence toward a role in calcium regulation. J. Immunol. 165, 1220-1227 (2000).
93. Tamir, I. et al. The RasGAP-binding protein p62dok is a mediator of inhibitory FcγRIIB signals in B cells. Immunity 12, 347-358 (2000).
94. Yamanashi, Y. et al. Role of the rasGAP-associated docking protein p62(dok) in negative regulation of B-cell receptor-mediated signaling. Genes Dev. 14, 11-16 (2000).
95. Suzuki, A. et al. T-cell-specific loss of Pten leads to defects in central and peripheral tolerance. Immunity 14, 523-534 (2001).
96. Torres, J. & Pulido, R. The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C-terminus. Implications for PTEN stability to proteasome-mediated degradation. J. Biol. Chem. 276, 993-998 (2001).
97. 2+ channel by INAD in Drosophila photoreceptors. Neuron 16, 991-998 (1996).
98. Tsunoda, S. et al. A multivalent PDZ-domain protein assembles signalling complexes in a G-protein-coupled cascade. Nature 388, 243-249 (1997).
99. Kabak, S. et al. The direct recruitment of BLNK to immunoglobulin α couples the B-cell antigen receptor to distal signaling pathway. Mol. Cell Biol. 22, 2524-2535 (2002).
100. Yamazaki, T. et al. Essential immunoregulatory role for BCAP in B-cell development and function. J. Exp. Med. 195, 535-545 (2002).
101. Reynolds, L. F. et al. Vav1 transduces T-cell receptor signals to the activation of phospolipase Cγ via phosphoinositide-3-kinase-dependent and -independent pathways. J. Exp. Med. (in the press).